Related Experiment Video
Updated: Jun 21, 2026
11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
MUC1 as a Putative Prognostic Marker for Prostate Cancer
Rona J Strawbridge1, Monica Nistér, Kerstin Brismar
1Departments of Oncology-Pathology.
Biomarker Insights
|July 7, 2009
Summary
Genetic variations in MUC1 (Mucin 1) are linked to prostate cancer risk. The study found a specific MUC1 gene variant (rs4072037 G allele) was less common in hereditary prostate cancer patients.
Area of Science:
- Biochemistry and Molecular Biology
- Oncology
- Genetics
Background:
- Mucin 1 (MUC1) is a glycoprotein expressed on glandular epithelium with roles in cell protection, adhesion, and signaling.
- MUC1 is implicated in prostate cancer development and progression.
- Alternative splicing generates MUC1 variants, with MUC1/1 and MUC1/2 distinguished by a single nucleotide polymorphism (SNP), rs4072037 (3506G>A).
Purpose of the Study:
- To investigate the association of the MUC1 rs4072037 SNP with prostate cancer, particularly hereditary forms.
- To explore potential genetic differences in MUC1 between blood and tumor tissues in prostate cancer patients.
Main Methods:
- Genotyping of the rs4072037 SNP in blood DNA from general population, benign prostatic hyperplasia (BPH), sporadic prostate cancer, and hereditary prostate cancer (HPC) cohorts.
- Analysis of matched blood and tumor DNA from sporadic prostate cancer patients.
- Bioinformatics analysis of MUC1 protein sequences to understand variant-specific functional differences.
Main Results:
- The G allele frequency of rs4072037 was significantly lower in hereditary prostate cancer (15%) compared to the general population (27%), BPH (39%), and sporadic prostate cancer (26%).
- Loss of the G allele was observed in 3 out of 8 heterozygous sporadic prostate tumors compared to their matched blood DNA.
- Bioinformatics analysis suggested potential functional distinctions between MUC1 splice variants.
Conclusions:
- The rs4072037 SNP in MUC1 shows a reduced frequency in hereditary prostate cancer, suggesting a potential role in genetic susceptibility.
- The observed allele loss in tumor tissue indicates potential genetic alterations of MUC1 during prostate cancer development.
- Further research using variant-specific antibodies and standardized methods is needed to elucidate the functional role and prognostic potential of MUC1 variants in prostate cancer.
